Skip to main content

Table 1 Baseline demographic and clinical participant characteristics (N = 253)

From: Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower

Variable N = 253 (baseline) n = 140 (completers) N = 113 (attriters)
Age, mean (SD) 55.7 (9.2) 55.1 (9.3) 56.5 (9.0)
Female, n (%) 226 (89.3) 124 (88.6) 102 (90.3)
Race n (%)
 White 231 (91.3) 126 (90.0) 105 (92.9)
 Black/African American 12 (4.7) 6 (4.3) 6 (5.3)
 Other 10 (4.0) 8 (5.7) 2 (1.8)
Hispanic n (%) 8 (3.2) 3 (2.1) 5 (4.4)
Condition, n (%)
 Osteoarthritis (OA) 164 (64.8) 87 (62.1) 77 (68.1)
 Rheumatoid arthritis (RA) 123 (48.6) 67 (47.9) 56 (49.6)
 Fibromyalgia syndrome (FMS) 102 (40.3) 56 (40.0) 46 (40.7)
 Psoriatic arthritis (PsA) 66 (26.1) 34 (24.3) 32 (28.3)
 Osteoporosis (OP) 53 (21.0) 34 (24.3) 19 (16.8)
 Ankylosing spondylitis (AS) 40 (15.8) 18 (12.9) 22 (19.5)
 Systemic lupus erythematosus (SLE) 15 (5.9) 6 (4.3) 9 (8.0)
BMI, mean (SD) 32.2 (8.7) 31.9 (9.1) 32.6 (8.3)
Number of years living with condition, mean (SD) 11.6 (10.6) 11.4 (10.8) 11.9 (10.3)
Married, n (%) 142 (56.1) 74 (52.9) 68 (60.2)
Education, n (%)
 Post-secondary school 230 (90.9) 129 (92.1) 101 (89.4)
Employment status, n (%)
 Currently employed (full-, part-time, self-employed) 93 (36.8) 52 (37.1) 41 (36.3)
Comorbid conditions, n (%)
 Depression 128 (50.6) 74 (52.9) 54 (47.8)
 Hypertension 116 (45.8) 64 (45.7) 52 (46.0)
 Hypercholesterolemia 89 (35.2) 49 (35.0) 40 (35.4)
 Psoriasis 62 (24.5) 31 (22.1) 31 (27.4)
 Diabetes 30 (11.9) 18 (12.9) 12 (10.6)
  1. T tests were performed for continuous variables and chi square tests or Fisher’s exact tests for categorical variables to compare the difference between groups of participants who completed and attrited. No statistical significance (p < 0.05) was observed